Table 2.
Cases tested, N (%) | Positive, N (%) | |
---|---|---|
Imaging diagnosis |
|
|
Endoscopy |
133 (79.17) |
130 (97.74) |
Gastroscopy |
26 (15.48) |
26 (100.00) |
Small intestinal endoscopy |
11 (6.55) |
8 (72.73) |
Proctoscopy |
96 (57.14) |
96 (100.00) |
Ultrasound |
82 (48.81) |
48 (58.54) |
Endoscopic ultrasound |
20 (11.90) |
18 (90.00) |
CT |
96 (57.14) |
52 (54.17) |
MRI |
17 (10.12) |
12 (70.59) |
PET-CT |
4 (2.38) |
3 (75.00) |
Immunohistochemistry |
|
|
Chromogranin A |
168 (100) |
122 (72.62) |
Synaptophysin |
168 (100) |
128 (76.19) |
NSE | 168 (100) | 55 (32.74) |
CT, computed tomography scan; MRI, magnetic resonance imaging; PET-CT, positron emission computed tomography; NSE, neuron-specific enolase.